Position in MRK
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$2,136,590
+$225,700 QoQ
Shares Held
17,762
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GM Advisory Group, LLC holds $19,630,085 across 10 Drug Manufacturers - General names. MRK ranks #3 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,002 | $9,199,539 | |
| 2 | JNJ |
Johnson & Johnson
|
14,495 | $3,543,157 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
17,762 | $2,136,590 | |
| 4 | ABBV |
AbbVie Inc.
|
7,400 | $1,609,426 | |
| 5 | PFE |
Pfizer Inc
|
32,594 | $915,239 | |
| 6 | AMGN |
Amgen Inc
|
2,556 | $899,328 | |
| 7 | AZN |
Astrazeneca PLC
|
2,421 | $477,469 | |
| 8 | NVS |
Novartis AG
|
2,102 | $321,080 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,136,590 | 17,762 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,910,890 | 18,154 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,308,468 | 15,590 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $1,583,358 | 20,002 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,769,169 | 19,710 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,867,429 | 58,981 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,978,129 | 43,837 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,245,901 | 42,374 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,638,751 | 42,734 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,484,606 | 31,963 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,122,931 | 20,621 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,404,727 | 20,840 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,824,056 | 17,145 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,080,098 | 9,735 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $838,378 | 9,735 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $895,289 | 9,820 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $806,141 | 9,825 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,087,904 | 14,195 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,055,671 | 14,055 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,071,281 | 13,775 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,289,793 | 16,731 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,955,100 | 23,901 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,247,282 | 27,092 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,044,992 | 26,445 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,886,721 | 24,522 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||